Malta vs Moldova: Colon and rectum cancer screening coverage in Europe
Malta
49.4%
in 2024
Moldova
44.6%
in 2024
Malta rank
8th
Moldova rank
9th
Colon and rectum cancer screening coverage in Europe over time
- Malta
- Moldova
How they compare
Malta currently reports 49.4% against 44.6% in Moldova, a difference of 4.8%.
That makes Malta's figure about 1.1 times Moldova's.
The two have swapped places 2 times across 7 shared years of data; in 2018 it was Malta ahead.
Malta ranks 8th and Moldova ranks 9th of 20 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.0% | 43.4% | 17.5% | Malta |
| 2020s | 48.3% | 39.2% | 9.1% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Malta or Moldova?
- Malta, at 49.4% against 44.6% in Moldova as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Malta and Moldova?
- 4.8%, with Malta ahead.
- How many years of comparable data are there for Malta and Moldova?
- 7 years are reported by both, from 2018 to 2024.
- How do Malta and Moldova rank globally for colon and rectum cancer screening coverage in europe?
- Malta ranks 8th and Moldova ranks 9th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.